- Home
- NPCE vs CLPT Comparison
NPCE vs CLPT Comparison
Compare NPCE & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NPCE | CLPT |
|---|---|---|
| Founded | 1997 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 485.6M | 494.6M |
| IPO Year | 2021 | 2009 |
Fundamental Metrics
Financial Performance| Metric | NPCE | CLPT |
|---|---|---|
| Price | $14.09 | $10.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $18.33 | ★ $21.50 |
| AVG Volume (30 Days) | 198.5K | ★ 930.3K |
| Earning Date | 05-25-2026 | 04-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.03 | 22.22 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $99,986,000.00 | $31,390,000.00 |
| Revenue This Year | $0.93 | $18.93 |
| Revenue Next Year | $25.47 | $51.64 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 25.13 | ★ 31.04 |
| 52 Week Low | $7.56 | $8.63 |
| 52 Week High | $18.97 | $30.10 |
Technical Indicators
Market Signals| Indicator | NPCE | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 42.38 | 41.50 |
| Support Level | $12.47 | $10.57 |
| Resistance Level | $16.96 | $11.69 |
| Average True Range (ATR) | 0.82 | 1.01 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 46.20 | 31.38 |
Price Performance
Historical ComparisonAbout NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.